Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Trends in the analysis of falsified and illegal medicines.

Deconinck E.

Talanta. 2019 Oct 1;203:328-329. doi: 10.1016/j.talanta.2019.05.074. Epub 2019 May 17. No abstract available.

PMID:
31202347
2.

Altered thymic CD4+ T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis.

Roussel X, Daguindau E, Berceanu A, Desbrosses Y, Saas P, Ferrand C, Seilles E, Pouthier F, Deconinck E, Larosa F.

Curr Res Transl Med. 2019 Jun 1. pii: S2452-3186(19)30019-4. doi: 10.1016/j.retram.2019.05.001. [Epub ahead of print]

PMID:
31164285
3.

Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT.

Ruggeri A, Labopin M, Savani B, Paviglianiti A, Blaise D, Volt F, Ciceri F, Bacigalupo A, Tischer J, Chevallier P, Koc Y, Cornelissen JJ, Ehninger G, Sanz G, Deconinck E, Rocha V, Baron F, Mohty M, Gluckman E, Nagler A.

Bone Marrow Transplant. 2019 May 31. doi: 10.1038/s41409-019-0582-5. [Epub ahead of print]

PMID:
31150016
4.

Lessons to be learned from toxicological analyses in intoxicated patients and seized materials at an electronic music dance festival.

Calle P, Maudens K, Lemoyne S, Geerts S, Van Sassenbroeck D, Jensen P, Van Overloop J, Deconinck E, Blanckaert P.

Forensic Sci Int. 2019 Jun;299:174-179. doi: 10.1016/j.forsciint.2019.03.047. Epub 2019 Apr 6.

PMID:
31039545
5.

A simple dilute-and-shoot method for screening and simultaneous quantification of nicotine and alkaloid impurities in electronic cigarette refills (e-liquids) by UHPLC-DAD.

Barhdadi S, Desmedt B, Courselle P, Rogiers V, Vanhaecke T, Deconinck E.

J Pharm Biomed Anal. 2019 May 30;169:225-234. doi: 10.1016/j.jpba.2019.03.002. Epub 2019 Mar 2.

PMID:
30877934
6.

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).

Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, Itälä-Remes M, Foá R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Reményi P, Nagler A, Finke J, Turlure P, Iacobelli S, van Biezen A, Schetelig J, Kröger N, Dreger P.

Bone Marrow Transplant. 2019 Jan 21. doi: 10.1038/s41409-019-0448-x. [Epub ahead of print]

PMID:
30664723
7.

Consumer protection provided by the European medical device and cosmetic legislation for condoms and lubricants.

Desmedt B, Vanhamme M, Vanhee C, Rogiers V, Deconinck E.

Regul Toxicol Pharmacol. 2019 Apr;103:106-112. doi: 10.1016/j.yrtph.2019.01.022. Epub 2019 Jan 16.

PMID:
30659873
8.

A strategy based on fingerprinting and chemometrics for the detection of regulated plants in plant food supplements from the Belgian market: Two case studies.

Deconinck E, Vanhamme M, Bothy JL, Courselle P.

J Pharm Biomed Anal. 2019 Mar 20;166:189-196. doi: 10.1016/j.jpba.2019.01.015. Epub 2019 Jan 11.

PMID:
30658317
9.

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos-channelopathy: A retrospective series of 126 patients.

Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, Bénéteau C, Berger C, Cathébras P, Deconinck E, Delaunay J, Durand JM, Firah N, Galactéros F, Godeau B, Jaïs X, de Jaureguiberry JP, Le Stradic C, Lifermann F, Maffre R, Morin G, Perrin J, Proulle V, Ruivard M, Toutain F, Lahary A, Garçon L.

Haematologica. 2019 Jan 17. pii: haematol.2018.205328. doi: 10.3324/haematol.2018.205328. [Epub ahead of print]

10.

Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.

Deconinck E, Van Campenhout R, Aouadi C, Canfyn M, Bothy JL, Gremeaux L, Blanckaert P, Courselle P.

Talanta. 2019 Apr 1;195:142-151. doi: 10.1016/j.talanta.2018.11.027. Epub 2018 Nov 12.

PMID:
30625524
11.

Development and validation of chromatographic methods for screening and subsequent quantification of suspected illegal antimicrobial drugs encountered on the Belgian market.

Tie Y, Vanhee C, Deconinck E, Adams E.

Talanta. 2019 Mar 1;194:876-887. doi: 10.1016/j.talanta.2018.10.078. Epub 2018 Oct 28.

PMID:
30609619
12.

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.

Warda W, Larosa F, Neto Da Rocha M, Trad R, Deconinck E, Fajloun Z, Faure C, Caillot D, Moldovan M, Valmary-Degano S, Biichle S, Daguindau E, Garnache-Ottou F, Tabruyn S, Adotevi O, Deschamps M, Ferrand C.

Cancer Res. 2019 Feb 1;79(3):663-675. doi: 10.1158/0008-5472.CAN-18-1078. Epub 2018 Dec 4.

PMID:
30514753
13.

Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission.

Poiré X, Labopin M, Polge E, Blaise D, Chevallier P, Maertens J, Deconinck E, Forcade E, Rambaldi A, Baerlocher GM, Zuckerman T, Volin L, Schouten HC, Ifrah N, Mohty M, Esteve J, Nagler A.

Am J Hematol. 2019 Feb;94(2):231-239. doi: 10.1002/ajh.25355. Epub 2018 Dec 10.

PMID:
30456896
14.

Falsification of biotechnology drugs: current dangers and/or future disasters?

Janvier S, De Spiegeleer B, Vanhee C, Deconinck E.

J Pharm Biomed Anal. 2018 Nov 30;161:175-191. doi: 10.1016/j.jpba.2018.08.037. Epub 2018 Aug 20. Review.

PMID:
30165334
15.

Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market.

Janvier S, Cheyns K, Canfyn M, Goscinny S, De Spiegeleer B, Vanhee C, Deconinck E.

Talanta. 2018 Oct 1;188:795-807. doi: 10.1016/j.talanta.2018.06.023. Epub 2018 Jun 15.

PMID:
30029448
16.

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

Adès L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, Marchand T, Récher C, Pigneux A, Girault S, Deconinck E, Gardin C, Tournilhac O, Lambert JF, Chevallier P, de Botton S, Lejeune J, Dombret H, Chevret S, Fenaux P.

Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.

17.

Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.

Gilleece MH, Labopin M, Yakoub-Agha I, Volin L, Socié G, Ljungman P, Huynh A, Deconinck E, Wu D, Bourhis JH, Cahn JY, Polge E, Mohty M, Savani BN, Nagler A.

Am J Hematol. 2018 Sep;93(9):1142-1152. doi: 10.1002/ajh.25211. Epub 2018 Aug 15.

PMID:
29981272
18.

Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Sociè G, Bourhis JH, Van Lint MT, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A.

Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.

19.

Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis.

Bellanger AP, Berceanu A, Rocchi S, Valot B, Fontan J, Chauchet A, Belin N, Scherer E, Deconinck E, Navellou JC, Millon L.

Bone Marrow Transplant. 2018 Sep;53(9):1180-1183. doi: 10.1038/s41409-018-0194-5. Epub 2018 Apr 30.

PMID:
29712993
20.

Factors related to the outcome of prophylactic platelet transfusions in patients with hematologic malignancies: an observational study.

Seigeot A, Desmarets M, Rumpler A, Leroux F, Deconinck E, Monnet E, Bardiaux L.

Transfusion. 2018 Jun;58(6):1377-1387. doi: 10.1111/trf.14592. Epub 2018 Mar 14.

PMID:
29542122
21.

Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation.

Cesaro S, Tridello G, Blijlevens N, Ljungman P, Craddock C, Michallet M, Martin A, Snowden JA, Mohty M, Maertens J, Passweg J, Petersen E, Nihtinen A, Isaksson C, Milpied N, Rohlich PS, Deconinck E, Crawley C, Ledoux MP, Hoek J, Nagler A, Styczynski J.

Clin Infect Dis. 2018 Aug 1;67(4):564-572. doi: 10.1093/cid/ciy150.

PMID:
29481599
22.

Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Tozatto-Maio K, Giannotti F, Labopin M, Ruggeri A, Volt F, Paviglianiti A, Kenzey C, Hayashi H, Cornelissen J, Michallet M, Karakasis D, Deconinck E, Rohrlich PS, de la Tour RP, Blaise D, Petersen E, D'Aveni M, Sengeloev H, Lamy T, Russell NH, Forcade E, Craddock CF, Nagler A, Gluckman E, Rocha V.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1657-1663. doi: 10.1016/j.bbmt.2018.02.014. Epub 2018 Mar 1.

PMID:
29477777
23.

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission.

Saraceni F, Labopin M, Hamladji RM, Mufti G, Socié G, Shimoni A, Delage J, Deconinck E, Chevallier P, Blaise D, Sanz J, Huynh A, Forcade E, Savani BN, Mohty M, Nagler A; Acute Leukemia Working Party of the European society for Blood and Marrow Transplantation (EBMT).

Oncotarget. 2017 Dec 15;9(3):3379-3393. doi: 10.18632/oncotarget.23273. eCollection 2018 Jan 9.

24.

Detection and identification of multiple adulterants in plant food supplements using attenuated total reflectance-Infrared spectroscopy.

Deconinck E, Aouadi C, Bothy JL, Courselle P.

J Pharm Biomed Anal. 2018 Apr 15;152:111-119. doi: 10.1016/j.jpba.2018.01.047. Epub 2018 Feb 3.

PMID:
29414001
25.

Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.

Garban F, Guyard A, Labussière H, Bulabois CE, Marchand T, Mounier C, Caillot D, Bay JO, Coiteux V, Schmidt-Tanguy A, Le Niger C, Robin C, Ladaique P, Lapusan S, Deconinck E, Rolland C, Foote AM, François A, Jacquot C, Tardivel R, Tiberghien P, Bosson JL; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group.

JAMA Oncol. 2018 Apr 1;4(4):468-475. doi: 10.1001/jamaoncol.2017.5123.

26.

Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.

Peffault de Latour R, Tabrizi R, Marcais A, Leblanc T, Lamy T, Mohty M, Tavitian S, Jubert C, Pasquet M, Galambrun C, Nguyen S, Cahn JY, Braun T, Deconinck E, Bay JO, Sicre de Fontbrune F, Barraco F, Socié G.

Am J Hematol. 2018 May;93(5):635-642. doi: 10.1002/ajh.25050. Epub 2018 Feb 14.

27.

A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice.

Schillinger F, Sourdeau E, Boubaya M, Baseggio L, Clauser S, Cornet E, Debord C, Defour JP, Dubois F, Eveillard M, Galoisy AC, Geay MO, Mullier F, Nivaggioni V, Soenen V, Morel P, Garnache-Ottou F, Ronez E, Bardet V, Deconinck E.

Scand J Clin Lab Invest. 2018 May;78(3):159-164. doi: 10.1080/00365513.2018.1423702. Epub 2018 Jan 8.

PMID:
29310473
28.

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1.

Versluis J, Labopin M, Ruggeri A, Socie G, Wu D, Volin L, Blaise D, Milpied N, Craddock C, Yakoub-Agha I, Maertens J, Ljungman P, Huynh A, Michallet M, Deconinck E, Chevallier P, Passweg J, Ciceri F, Mohty M, Cornelissen JJ, Nagler A.

Blood Adv. 2017 Feb 28;1(7):477-485. doi: 10.1182/bloodadvances.2016002386. eCollection 2017 Feb 28.

29.

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.

Shimoni A, Labopin M, Savani B, Hamladji RM, Beelen D, Mufti G, Socié G, Delage J, Blaise D, Chevallier P, Forcade E, Deconinck E, Mohty M, Nagler A.

Biol Blood Marrow Transplant. 2018 Apr;24(4):751-757. doi: 10.1016/j.bbmt.2017.12.776. Epub 2017 Dec 13.

30.

Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Huynh A, Beckerich F, Suarez F, Chevallier P, Nguyen-Quoc S, Ledoux MP, Clement L, Hicheri Y, Guillerm G, Cornillon J, Contentin N, Carre M, Maillard N, Mercier M, Mohty M, Beguin Y, Bourhis JH, Charbonnier A, Dauriac C, Bay JO, Blaise D, Deconinck E, Jubert C, Raus N, Peffault de Latour R, Dhedin N.

Am J Hematol. 2018 Mar;93(3):416-423. doi: 10.1002/ajh.25004. Epub 2018 Jan 8.

31.

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK.

J Intern Med. 2018 Apr;283(4):371-379. doi: 10.1111/joim.12720. Epub 2018 Jan 5.

32.

More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.

Tiberghien P, Deconinck E, Adotevi O.

N Engl J Med. 2017 Nov 23;377(21):2101-2. doi: 10.1056/NEJMc1712460. No abstract available.

PMID:
29182255
33.

Identification of coffee leaves using FT-NIR spectroscopy and SIMCA.

Mees C, Souard F, Delporte C, Deconinck E, Stoffelen P, Stévigny C, Kauffmann JM, De Braekeleer K.

Talanta. 2018 Jan 15;177:4-11. doi: 10.1016/j.talanta.2017.09.056. Epub 2017 Sep 23.

PMID:
29108581
34.

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.

Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Le Du K, Benchalal M, Moles MP, Le Gouill S, Fleury J, Godmer P, Maisonneuve H, Deconinck E, Houot R, Laribi K, Marolleau JP, Tournilhac O, Branger B, Devillers A, Vuillez JP, Fest T, Colombat P, Costes V, Szablewski V, Béné MC, Delwail V; LYSA Group.

Blood. 2018 Jan 11;131(2):174-181. doi: 10.1182/blood-2017-07-793984. Epub 2017 Oct 23.

35.

Are injectable illegal polypeptide drugs safe? Case report demonstrating the presence of haemolytic Bacillus cereus in 2 illegal peptide drugs.

Janvier S, Wattijn E, Botteldoorn N, De Spiegeleer B, Deconinck E, Vanhee C.

Drug Test Anal. 2018 Apr;10(4):791-795. doi: 10.1002/dta.2304. Epub 2017 Dec 1. No abstract available.

PMID:
28941153
36.

Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Le Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, Peffault de Latour R, Marçais A, Bulabois CE, Bay JO, Chantepie S, Deconinck E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Mercier M, Turlure P, Charbonnier A, Rorhlich PS, N'Guyen S, Maillard N, Marchand T, Mohty M, Chevallier P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Ann Oncol. 2017 Sep 1;28(9):2191-2198. doi: 10.1093/annonc/mdx274.

PMID:
28911060
37.

Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.

Philippe L, Ceroi A, Bôle-Richard E, Jenvrin A, Biichle S, Perrin S, Limat S, Bonnefoy F, Deconinck E, Saas P, Garnache-Ottou F, Angelot-Delettre F.

Haematologica. 2017 Nov;102(11):1861-1868. doi: 10.3324/haematol.2017.169326. Epub 2017 Aug 10.

38.

Analysis of illegal peptide drugs via HILIC-DAD-MS.

Janvier S, De Sutter E, Wynendaele E, De Spiegeleer B, Vanhee C, Deconinck E.

Talanta. 2017 Nov 1;174:562-571. doi: 10.1016/j.talanta.2017.06.034. Epub 2017 Jun 13.

PMID:
28738623
39.

Chemometrics and chromatographic fingerprints to classify plant food supplements according to the content of regulated plants.

Deconinck E, Sokeng Djiogo CA, Courselle P.

J Pharm Biomed Anal. 2017 Sep 5;143:48-55. doi: 10.1016/j.jpba.2017.05.032. Epub 2017 May 20.

PMID:
28554127
40.

Development and validation of a HS/GC-MS method for the simultaneous analysis of diacetyl and acetylpropionyl in electronic cigarette refills.

Barhdadi S, Canfyn M, Courselle P, Rogiers V, Vanhaecke T, Deconinck E.

J Pharm Biomed Anal. 2017 Aug 5;142:218-224. doi: 10.1016/j.jpba.2017.04.050. Epub 2017 May 4.

PMID:
28521275
41.

Detection of regulated herbs and plants in plant food supplements and traditional medicines using infrared spectroscopy.

Deconinck E, Djiogo CAS, Bothy JL, Courselle P.

J Pharm Biomed Anal. 2017 Aug 5;142:210-217. doi: 10.1016/j.jpba.2017.04.051. Epub 2017 May 8.

PMID:
28521274
42.

The use of Stationary Phase Optimized Selectivity Liquid Chromatography for the development of herbal fingerprints to detect targeted plants in plant food supplements.

Deconinck E, Djiogo CAS, Kamugisha A, Courselle P.

Talanta. 2017 Aug 1;170:441-450. doi: 10.1016/j.talanta.2017.04.028. Epub 2017 Apr 19.

PMID:
28501194
43.

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.

Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A.

Am J Hematol. 2017 Jul;92(7):653-659. doi: 10.1002/ajh.24737. Epub 2017 May 26.

44.

Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.

Bellanger AP, Cervoni JP, Faucher JF, Weil-Verhoeven D, Ginet M, Deconinck E, Grenouillet F.

Mycopathologia. 2017 Aug;182(7-8):761-765. doi: 10.1007/s11046-017-0131-y. Epub 2017 Apr 1.

PMID:
28365835
45.

Chromatographic fingerprinting as a strategy to identify regulated plants in illegal herbal supplements.

Custers D, Van Praag N, Courselle P, Apers S, Deconinck E.

Talanta. 2017 Mar 1;164:490-502. doi: 10.1016/j.talanta.2016.12.008. Epub 2016 Dec 6.

PMID:
28107963
46.

DNA damage response defect in Williams-Beuren syndrome.

Guenat D, Merla G, Deconinck E, Borg C, Rohrlich PS.

Int J Mol Med. 2017 Mar;39(3):622-628. doi: 10.3892/ijmm.2017.2861. Epub 2017 Jan 17.

47.

Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA.

Wang L, Raffoux E, Thomas X, Yakoub-Agha I, Bouhris JH, de Botton S, Michallet M, Quoc SN, Chantepie S, Deconinck E, Caillot D, Turlure P, Vigouroux S, Pigneux A, Huynh A, Malfuson JV, Loschi M, Socie G, Dombret H, de la Tour RP, Cluzeau T.

Leuk Res. 2017 Mar;54:12-16. doi: 10.1016/j.leukres.2017.01.002. Epub 2017 Jan 5.

PMID:
28088653
48.

Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.

Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A.

Am J Hematol. 2017 Apr;92(4):344-350. doi: 10.1002/ajh.24640. Epub 2017 Feb 7.

49.

In vitro Dermal Absorption of Hydroquinone: Protocol Validation and Applicability on Illegal Skin-Whitening Cosmetics.

Desmedt B, Ates G, Courselle P, De Beer JO, Rogiers V, Hendrickx B, Deconinck E, De Paepe K.

Skin Pharmacol Physiol. 2016;29(6):300-308. doi: 10.1159/000454719. Epub 2017 Jan 5.

50.

A simple dilute and shoot methodology for the identification and quantification of illegal insulin.

Vanhee C, Janvier S, Moens G, Deconinck E, Courselle P.

J Pharm Anal. 2016 Oct;6(5):326-334. doi: 10.1016/j.jpha.2016.04.006. Epub 2016 Apr 22.

Supplemental Content

Loading ...
Support Center